Effect of sitagliptin on the pharmacokinetics of simvastatin.
Bergman
Arthur J
AJ
Department of Experimental Medicine, Merck Research Laboratories, RY34-A400, 126 East Lincoln Avenue, Rahway, NJ 07065, USA.
Cote
Josee
J
Maes
Andrea
A
Zhao
Jamie J
JJ
Roadcap
Brad A
BA
Sun
Li
L
Valesky
Robert J
RJ
Yang
Amy
A
Keymeulen
Bart
B
Mathijs
Zissi
Z
De Smet
Marina
M
Laethem
Tine
T
Davies
Michael J
MJ
Wagner
John A
JA
Herman
Gary A
GA
D000328:Adult; D018592:Cross-Over Studies; D054873:Dipeptidyl-Peptidase IV Inhibitors / Q000008:administration & dosage*; D004347:Drug Interactions; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000493:pharmacokinetics*; D000960:Hypolipidemic Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D008297:Male; D011719:Pyrazines / Q000008:administration & dosage / Q000494:pharmacology*; D019821:Simvastatin / Q000008:administration & dosage / Q000493:pharmacokinetics*; D000068900:Sitagliptin Phosphate; D013997:Time Factors; D014230:Triazoles / Q000008:administration & dosage / Q000494:pharmacology*
D054873:Dipeptidyl-Peptidase IV Inhibitors; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents; D011719:Pyrazines; D014230:Triazoles; D019821:Simvastatin; D000068900:Sitagliptin Phosphate